New Promega Water-Glo™ System Combines ATP Detection and Bioluminescence Technologies for Quick, Highly Sensitive Water Quality Testing

Madison, WI USA. (March 12, 2019) Promega Corporation’s new Water-Glo™ System offers water plant operators a rapid, highly sensitive and flexible measurement tool for monitoring microbial contamination in freshwater, process water, seawater or wastewater samples. The Water-Glo™ System, launched by Promega this week, uses bioluminescent technology to measure adenosine triphosphate or ATP, the “energy currency” of all living... Read more

Lonza’s New Spheroid-Forming Human Hepatocytes Facilitate Improved In Vitro Liver Model Systems

Walkersville, MD (USA) / Basel (CH), 4 March 2019 – Lonza has further expanded its hepatocytes portfolio characterization with the addition of Verified for Spheroids™ Human Hepatocytes, which are pre-screened for their ability to promote rapid spheroid formation in cell culture. Researchers working in toxicology, disease modeling and DMPK studies can now feel more confident... Read more

DNAnexus Introduces Innovative Clinico-Genomic Browser to Allow Diverse Research Teams to Explore Complex Human Data Sets

The Regeneron Genetics Center successfully deployed the cohort browser against a large genomic and phenotypic UK Biobank data set March 11, 2019 09:15 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the addition of an innovative browser for clinico-genomic cohorts to its DNAnexus Apollo™... Read more

ParticleScout, a new analysis tool for faster detection, classification and identification of microparticles

Determine physical and chemical properties with confocal Raman microscopy. WITec GmbH, pioneer of Raman imaging and correlative microscopy, has introduced ParticleScout, a revolutionary particle analysis tool for the alpha300 Raman microscope series. It enables researchers to find, classify, quantify and identify particles quickly and easily. ParticleScout delivers a greatly accelerated workflow to the researcher investigating... Read more

Shimadzu’s New Shim-Pack Arata LC Columns Provide Unprecedented Resolution and Peak Shape of Basic Compounds

Mar 08 2019 Shimadzu Scientific Instruments (SSI) announces the release of the new Shim-pack Arata LC columns to provide unmatched peak shape for high pH compounds. These columns solve the resolution challenges of analyzing basic compounds, such as leading of highly polar basic compounds, peak shape deterioration of acidic compounds, or long equilibration time required... Read more

AMETEK Spectro Scientific Expands Its TruVu 360™ Enterprise Fluid Intelligence Platform with New Configurations

Friday, March 8, 2019 CHELMSFORD, MASS. – AMETEK Spectro Scientific, one of the world’s largest suppliers of oil, fuel and processed-water analysis instrumentation and software, expanded its cloud-based TruVu 360™ Enterprise Fluid Intelligence Platform with two standalone versions — TruVu 360 Basic and TruVu 360 Pro — both of which can be installed on a... Read more

Solid.Line family gains new additions

07 March 2019 BINDER’s constant climate chambers are increasingly being tailored to meet the specific requirements of users. Following the successful launch of the Solid.Line range of constant climate chambers, featuring interior volumes of 240 and 720 liters, the family is now welcoming two new additions that will allow the Tuttlingen-based company to accommodate its customers’... Read more

Nuvec®: A breakthrough technology for mRNA / pDNA delivery for vaccines and cancer treatments

N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company, is developing Nuvec® – a unique non-viral adjuvant delivery system for vaccines and cancer treatments. This silica nanoparticle has the potential to help commercialize cancer immunotherapy drugs and improve the effectiveness of viral vaccines. Nuvec® silica nanoparticles have a unique irregular (spikey) surface structure, coupled with... Read more

Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions

Basel, 07 March 2019 Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions Application is being reviewed under FDA’s Real-Time Oncology Review pilot programme Combination was granted Breakthrough Therapy Designation, the fifth for Venclexta Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced... Read more